Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology

1 · Sector

Weight and 12M allocation change

Information Technology28.6%+15.24 ppHealth Care16.6%+8.70 ppFinancials13.3%+6.14 ppIndustrials10.2%+4.03 ppConsumer Staples7.5%+3.95 ppEnergy3.1%+1.92 ppReal Estate3.2%+1.74 ppUtilities3.2%+1.64 ppMaterials3.2%+1.62 ppCommunication Services3.9%+1.42 ppConsumer Discretionary7.2%-46.41 pp

2 · Industry

Inside Health Care

Pharmaceuticals4.80%+2.43 ppHealth Care Equipment3.31%+1.65 ppManaged Health Care2.29%+1.35 ppBiotechnology2.39%+1.28 ppLife Sciences Tools & Services2.05%+1.06 ppHealth Care Services0.90%+0.48 ppHealth Care Distributors0.34%+0.20 ppHealth Care Facilities0.26%+0.15 ppHealth Care Supplies0.26%+0.12 ppHealth Care Technology0.00%+0.00 pp

3 · Sub-industry

Inside Biotechnology

Biotechnology2.39%+1.280 pp
Concentrated

Most of this industry's gains came from a few companies.

View all contributions →
Biotechnology · weight
2.39%
Industry change · 12M
+1.28 pp
Biotechnology · contribution
+1.280 pp
Company participation
63%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2022 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$261.4bn0.907%+0.218 pp+0.526 pp+43.5%Yes
Moderna →
MRNA
United States$61.9bn0.215%-0.268 pp+0.215 pp-0.8%No
Amgen →
AMGN
United States$126.2bn0.438%+0.059 pp+0.178 pp+3.9%Yes
Regeneron Pharmaceuticals →
REGN
United States$58.1bn0.202%-0.001 pp+0.117 pp+37.2%Yes
Gilead Sciences →
GILD
United States$75.7bn0.263%-0.029 pp+0.109 pp+2.6%No
Vertex Pharmaceuticals →
VRTX
United States$58.6bn0.203%+0.043 pp+0.093 pp+8.2%Yes
Biogen →
BIIB
United States$31.0bn0.108%-0.009 pp+0.024 pp-22.7%No
Incyte →
INCY
United States$15.1bn0.052%+0.002 pp+0.018 pp-13.2%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.